Estimativas de analistas de Wall Street para Ironwood Pharmaceuticals, Inc. (IRWD): preço alvo de consenso, recomendações de compra/manter/venda e previsões de receita, LPA e EBITDA para os próximos exercícios.
Surpresas de Resultados Recentes
| Data | LPA Real | LPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-09 | $0.30 | ||
| 2026-08-06 | $0.31 | $0.32 | -3.1% |
| 2026-05-07 | $0.24 | $0.07 | +242.9% |
| 2026-02-25 | $-0.01 | $0.02 | -150.0% |
| 2025-11-10 | $0.24 | $0.09 | +166.7% |
| 2025-08-07 | $0.14 | $-0.02 | +800.0% |
| 2025-05-07 | $-0.23 | $-0.05 | -360.0% |
| 2025-02-27 | $0.02 | $0.12 | -83.3% |
Demonstração de Resultados (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Receita | $274.0M | $298.3M | $346.6M | $428.4M | $389.5M | $413.8M | $410.6M | $442.7M | $351.4M | $296.2M |
| Custo da Receita | $1.9M | $19.4M | $32.8M | $135.4M | $3.1M | $70.4M | $1.4M | $6.1M | $7.6M | 0 |
| Lucro Bruto | $272.1M | $278.9M | $313.9M | $293.0M | $386.4M | $343.3M | $409.2M | $436.6M | $343.9M | $296.2M |
| P&D | $139.5M | $148.2M | $166.5M | $122.2M | $88.1M | $70.4M | $44.3M | $116.1M | $111.4M | $95.1M |
| Despesas Gerais e Administrativas | $173.3M | $233.1M | $241.3M | 0 | $140.0M | 0 | $116.0M | 0 | 0 | $82.3M |
| Despesas Operacionais | $313.8M | $387.6M | $415.9M | $172.9M | $243.4M | $111.1M | $158.8M | $1.38B | $250.7M | $177.4M |
| Lucro Operacional | -$51.9M | -$77.4M | -$238.9M | $120.1M | $142.9M | $232.3M | $250.3M | -$945.4M | $93.1M | $118.8M |
| EBITDA | -$31.3M | -$33.1M | -$144.5M | $128.6M | $141.9M | $233.7M | $261.4M | $197.4M | $97.7M | $104.7M |
| Despesas com Juros | $39.2M | $36.4M | $37.7M | $36.6M | $29.5M | $31.1M | $7.6M | $21.6M | $33.0M | $32.7M |
| Lucro Antes de Impostos | -$81.7M | -$116.9M | -$282.4M | $58.9M | $108.9M | $200.7M | $252.4M | -$948.1M | $65.2M | $70.0M |
| Imposto | 0 | $34.3M | -$5.8M | 0 | $2.7M | -$327.8M | $77.4M | $83.5M | $64.3M | $46.0M |
| Lucro Líquido | -$81.7M | -$116.9M | -$282.4M | $21.5M | $106.2M | $528.4M | $175.1M | -$1.00B | $880000 | $24.0M |
| LPA | $-0.56 | $-0.79 | $-1.85 | $0.38 | $0.67 | $3.26 | $1.13 | $-6.45 | $0.01 | $0.15 |
| LPA Diluído | $-0.56 | $-0.78 | $-1.85 | $0.38 | $0.66 | $3.21 | $0.96 | $-6.45 | $0.01 | $0.15 |
| Ações em Circulação (Diluídas) | $145.9M | $149.0M | $152.6M | $156.0M | $160.7M | $164.4M | $186.3M | $155.4M | $160.1M | $177.8M |
Preço
| Preço | $4.17 |
| Capitalização | $686M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ACB · ALDX · BIOA · CGC · CLLS · GNLX · LFCR
Explorar setor: Healthcare · Drug Manufacturers - Specialty & Generic
Mais seções de IRWD: Resumo · Financeiros · Avaliação · Estatísticas · Técnico · Propriedade · Notícias · Eventos
Descubra mais: Radar — sinais de ações subvalorizadas · Academia de Investimento — aprenda a analisar ações